PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23824327-4	2013	Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq).	arsenite	69-77	argonaute RISC catalytic component 2	Homo sapiens	41-45	
18476811-4	2008	Phosphorylation of Ago2 at serine-387 was significantly induced by treatment with sodium arsenite or anisomycin, and arsenite-induced phosphorylation was inhibited by a p38 MAPK (mitogen-activated protein kinase) inhibitor, but not by inhibitors of JNK (c-Jun N-terminal kinase) or MEK [MAPK/ERK (extracellular-signal-regulated kinase) kinase].	arsenite	89-97	argonaute RISC catalytic component 2	Homo sapiens	19-23	
30404558-6	2019	In non-RNAi cells, arsenite induced the accumulation of Ago2 in SGs as shown by its colocalization and coimmunoprecipitation with SG proteins, but Ago2 was not recruited to SG in the cells with RNAi.	arsenite	19-27	argonaute RISC catalytic component 2	Homo sapiens	56-60	
30404558-7	2019	Consistently, arsenite induced the dissociation of Ago2 from RISC proteins in non-RNAi cells but not in RNAi cells.	arsenite	14-22	argonaute RISC catalytic component 2	Homo sapiens	51-55	
30404558-8	2019	CRISPR-Cas9-medicated ablation of Ago2 attenuated SG formation during arsenite treatment, suggesting a critical role of Ago2 in SG assembly.	arsenite	70-78	argonaute RISC catalytic component 2	Homo sapiens	34-38